申请人:NAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING
公开号:WO2018014802A1
公开(公告)日:2018-01-25
The invention provides compounds that are inhibitors or covalent modifiers of succinate dehydrogenase subunit B (SDHB) and/or inhibitors of apoptosis, and pharmaceutically acceptable salts, hydrides and stereoisomers thereof. The compounds are employed in pharmaceutical compositions, and methods of making and use, including treating a person in need thereof with an effective amount of the compound or composition.
这项发明提供了一种抑制琥珀酸脱氢酶亚基B(SDHB)或共价修饰剂的化合物,以及抑制凋亡的化合物,以及这些化合物的药用盐、氢化物和立体异构体。这些化合物用于制备药物组合物,以及制备和使用方法,包括使用有效量的化合物或组合物治疗需要的人。